News & Updates

Lung Cancer Canada Names New President

Lung Cancer Canada held its AGM on June 14, electing a new President and one new board member to LCC’s Board of Directors.
 

What's New In: Mesothelioma

A panel discussion of the latest advances inthe treatment of Mesothelioma. Featuring Dr Anna Nowak and Dr. Dr Quincy Chu. Moderated by Dr. Paul Wheatley-Price.

Urgent Changes Needed

Cancer patient groups across Canada call for 2nd COVID-19 dose to be given to cancer patients according to best evidence- 21 to 28 days, not 4 weeks. 

Alberta Changes 2nd COVID-19 Vaccine Dose Guidelines

Alberta approves 21 or 28 day COVID-19 vaccine interval for cancer patients on active treatment

Joint Cancer Action on the Second Dose of the COVID-19 Vaccine

Lymphoma Canada, Myeloma Canada, Save Your Skin Foundation and Lung Cancer Canada ask the Provincial Governments for timely administration of second COVID-19 vaccines for immunocompromised patients, prioritization of the vaccine for household members of patients receiving immunosuppressive therapy, and increased guidance on the COVID-19 vaccine specific for cancer patients.

Global Lung Cancer Coalition Patient Experience Survey

Join lung cancer patients around the world who are sharing their experience of lung cancer care.

New COVID-19 Vaccine Recommendations for Cancer Patients

New Ontario VCAG recommendations for COVID-19 vaccine intervals for cancer patients.

What's New In: Immunotherapy

A panel discussion of the latest advances in immunotherapy for the treatment of lung cancer. Featuring Dr. Julie Brahmer and Dr. Rosalyn Juergens. Moderated by Dr. Paul Wheatley-Price.

Displaying results 1-10 (of 86)
 |<  < 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9  >  >|